Case report
A 63 year old retired caterer presented with a two month history of dry cough and wheezing. Her tolerance of exercise was 400 metres on the flat, she had no orthopnoea but became breathless on stairs. She smoked 20 cigarettes a day, had lost 6 kg over the past year, but denied any abdominal pain, anorexia, or blackouts. Her menstruation had been normal until the age of 50, and she had one son aged 36.
On examination she was deeply tanned with pigmented palmar creases and intraoral pigmentation. She had no axillary hair and scanty pubic hair. Her blood pressure was 95/70 mm Hg when supine and 85/75 mmHg when standing. She had a widespread expiratory wheeze; peak flow was 150 I/min, forced expiratory volume in one second 1 3 1, and forced vital capacity 1-5 1. The plasma concentration of sodium was 129 mmol/l, potassium 4-5 mmol/l, and urea 8-6 mmol/l; haemoglobin was 136 g/l, white cell count 5 05x102/1 (8% eosinophils), and erythrocyte sedimentation rate 9 mm in first hour. The results of tests of liver and thyroid function were normal. Plasma cortisol concentrations during three short tests with tetracosactrin were 120 nmol/l, 140 nmol/l, and 120 nmol/l, the lack of a cortisol response being confirmed by a long test with tetracosactrin. Luteinising and follicle stimulating hormone concentrations were both in the menopausal range (>50 U/1), and adrenocorticotrophic hormone was 266 7 pmol/l (normal 2 2-17 8 pmol/l). Respiratory muscle studies2 showed low maximal static expiratory mouth pressure (34 cm H20; normal >32 cm H20), low maximal static inspiratory mouth pressure (14 cm H20; normal >24 cm H20), and reduced transdiaphragmatic pressure during maximal sniffs3 (48 cm H20; normal >70 cm H20). Phrenic nerve conduction times were 9 ms (normal 5-9 5 ms). Maximal voluntary contraction of the quadriceps muscles was 9 kg (normal >29 kg).
Full replacement treatment with hydrocortisone acetate was started. Ten months later her breathlessness had improved such that she was able to climb two flights of stairs. Peak flow had increased to 315 1/min, forced expiratory volume in one second to 1-6 1, and forced vital capacity to 2 5 1. Maximal static expiratory mouth pressure had increased to 45 cm H20, maximal static inspiratory mouth pressure to 20 cm H20, and transdiaphragmatic pressure during maximal sniffs to 75 cm H20. Phrenic nerve conduction times were unchanged. Maximal voluntary contraction of the quadriceps muscles increased to 22 kg.
Comment
In Addison's disease generalised fatigue is common and is usually attributed to non-specific malaise rather than muscle weakness. Our patient, however, showed evidence of weakness in both respiratory and quadriceps muscles, suggesting that all skeletal muscles were affected. Phrenic neuropathy was excluded by the finding of normal conduction times in the phrenic nerve. Although electrolyte disturbances may have partially contributed, weakness in the respiratory muscles probably resulted mainly from myopathy. Thus just as steroid myopathy may be induced by Cushing's syndrome or by excessive corticosteroid administration, so a lack of corticosteroid also seems to result in muscle weakness and myopathy.
Our patient had airways obstruction that improved after treatment. She also had diaphragmatic weakness of moderate severity, which can produce dyspnoea on exertion4; this may improve as the diaphragmatic weakness resolves in cases in which a treatable cause for respiratory muscle dysfunction exists.' In our patient the strength of quadriceps muscle' and function of expiratory and diaphragmatic muscles returned to within the normal range after treatment; low values for maximal static inspiratory mouth pressures seemed to be due to poor technique, a not uncommon finding with this manoeuvre. We conclude that Addison's disease can cause myopathy which may affect the respiratory muscles. Patients, methods, and results We studied plasma carotene concentrations in a group of elderly women who had Alzheimer's disease (mean age 86 (range 71-94)). Two control groupsnamely, women who had multi-infarct dementia (mean age 83 (72-94)) and non-demented long stay elderly women (mean age 81 (70-89))--were also studied.
Altogether there were 63 patients. Dementia was diagnosed from clinical criteria, and the Hachinski score2 was used to differentiate patients who had multiinfarct dementia from those who had Alzheimer's disease. We, measured plasma carotene concentrations spectrophotometrically and also studied the relation between plasma carotene and plasma vitamin A concentrations, as dietary carotene is a source of vitamin A. In addition, thyroid function and plasma lipid concentrations3 were studied. Tests of thyroid function were performed on patients in all three groups, and lipid profiles were determined in the groups who had Alzheimer's disease and multi-infarct dementia.
A considerable difference in carotene concentrations was found among the Alzheimer group and the control groups (figure), but no significant differences in vitamin A concentrations were found. Lipid profiles were available for 12 patients in the Alzheimer group and 15 patients in the multi-infarct group. There was no significant difference between the mean values for the two groups. There were, however, significant differences (p<005, Mann-Whitney U test) between the Alzheimer group and the non-demented group in total thyroxine concentrations (mean (SEM) 86-7 (3 4) nmol/l v 97 6 (4 9) nmol/l) and free thyroxine indices (168-2 (44) v 1940 (10 3) 
